Tenaya Therapeutics Secures $106 Million in Series C Funding to Accelerate Pipeline of Potentially Curative Therapies for Heart Disease
Amount Raised
$106 Million
Round Type
Series C
South San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Tenaya Therapeutics, a biotechnology company whose mission is to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced that it has secured $106 million in Series C funding. Founded by leading cardiovascular scientists from the Gladstone Institutes and UT Southwestern (UTSW), Tenaya is advancing programs across three therapeutic platforms to address heart disease: Gene Therapy, Cellular Regeneration and Precision Medicine.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Tenaya Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Alchemab Therapeutics raised $78M (Series A) on April 15, 2021.
- CUREMARK LLC raised $1.5M (Seed) on April 14, 2021.
- Repertoire Immune Medicines raised $189M (Funding Round) on April 13, 2021.
- Aura Biosciences, Inc. raised $80M on April 6, 2021.
- Artiva Biotherapeutics raised $120M on April 5, 2021.
- AbSci Corp raised $125M on March 30, 2021.
Who to call at Tenaya Therapeutics, and when
A new round usually means Tenaya Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tenaya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tenaya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tenaya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tenaya Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Tenaya Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.